152P Immunotherapy for extensive-stage SCLC: Uncovering clinical gaps in physician knowledge and practice

V.H.J Harvey-Jones,A Furedy,J Vandenbroucque,M Reck

doi:10.1016/j.annonc.2022.02.183

152P Immunotherapy for extensive-stage SCLC: Uncovering clinical gaps in physician knowledge and practice

V.H.J Harvey-Jones, A Furedy + Show 2 more

Open Access

https://doi.org/10.1016/j.annonc.2022.02.183

Copy DOI

Journal: Annals of oncology : official journal of the European Society for Medical Oncology	Publication Date: Apr 1, 2022
License type: elsevier-specific: oa user license

Affiliation: Health Education England, German Center for Lung Research

#Gaps In Knowledge #Extensive-stage Small Cell Lung Cancer + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Immune checkpoint inhibitors (ICIs) are changing the management of extensive-stage small cell lung cancer (ES-SCLC). This activity was designed to understand the gaps in knowledge, competence and confidence of oncologists regarding ICI use for treating ES-SCLC.

Full Text